APO Research
Talk to an analyst

APO RESEARCH · REPORT

Dry Eye Syndrome Treatment

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Dry Eye Syndrome Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

23 December 2025198 pages

Choose your research edition.

Industry ResearchDry Eye Syndrome Treatment Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal Dry Eye Syndrome Treatment Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Dry Eye Syndrome Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Dry Eye Syndrome Treatment Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal Dry Eye Syndrome Treatment Market Analysis and Forecast 2026-2032203 pages · $4,950 USD

Market perspective

The global Dry Eye Syndrome Treatment market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Dry Eye Syndrome Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Dry Eye Syndrome Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Dry Eye Syndrome Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Dry Eye Syndrome Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Dry Eye Syndrome Treatment include Sun Pharmaceutical, Johnson & Johnson, Novartis, United Laboratories, Jianfeng Group, Alcon, AbbVie, URSAPHARM and Thea pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Dry Eye Syndrome Treatment market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Dry Eye Syndrome Treatment and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Dry Eye Syndrome Treatment sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Dry Eye Syndrome Treatment market size, projected growth trends, production technologies, key applications, and end-use industries.

Dry Eye Syndrome Treatment Segment by Company

Sun Pharmaceutical

Johnson & Johnson

Novartis

United Laboratories

Jianfeng Group

Alcon

AbbVie

URSAPHARM

Thea pharmaceuticals

SIMILASAN

Santen Pharma

Rohto

Prestige Consumer Healthcare

OmniVision Pharma

LION

Kenvue (VISINE)

Bausch & Lomb

Akorn

Dry Eye Syndrome Treatment Segment by Type

Liquid Wipes

Liquid Drops

Eye Ointment

Gel

Other

Dry Eye Syndrome Treatment Segment by Application

Clinic

Hospital

Home Care

Dry Eye Syndrome Treatment Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dry Eye Syndrome Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Dry Eye Syndrome Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dry Eye Syndrome Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Dry Eye Syndrome Treatment market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Dry Eye Syndrome Treatment manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Dry Eye Syndrome Treatment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Dry Eye Syndrome Treatment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Dry Eye Syndrome Treatment Industry Trends Table 2. Dry Eye Syndrome Treatment Industry Drivers Table 3. Dry Eye Syndrome Treatment Industry Opportunities and Challenges Table 4. Dry Eye Syndrome Treatment Industry Restraints Table 5. Global Dry Eye Syndrome Treatment Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Dry Eye Syndrome Treatment Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Dry Eye Syndrome Treatment Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Dry Eye Syndrome Treatment Sales Market Share by Manufacturers Table 9. Global Dry Eye Syndrome Treatment Average Sales Price (USD/unit) of Manufacturers (2021-2026) Table 10. Global Dry Eye Syndrome Treatment Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Dry Eye Syndrome Treatment Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Dry Eye Syndrome Treatment Manufacturers, Product Type & Application Table 13. Global Dry Eye Syndrome Treatment Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Dry Eye Syndrome Treatment by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Liquid Wipes Table 17. Major Manufacturers of Liquid Drops Table 18. Major Manufacturers of Eye Ointment Table 19. Major Manufacturers of Gel Table 20. Major Manufacturers of Other Table 21. Global Dry Eye Syndrome Treatment Sales by Type 2021 VS 2025 VS 2032 (k units) Table 22. Global Dry Eye Syndrome Treatment Sales by Type (2021-2026) & (k units) Table 23. Global Dry Eye Syndrome Treatment Sales by Type (2027-2032) & (k units) Table 24. Global Dry Eye Syndrome Treatment Sales Market Share by Type (2021-2026) Table 25. Global Dry Eye Syndrome Treatment Sales Market Share by Type (2027-2032) Table 26. Global Dry Eye Syndrome Treatment Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 27. Global Dry Eye Syndrome Treatment Revenue by Type (2021-2026) & (k units) Table 28. Global Dry Eye Syndrome Treatment Revenue by Type (2027-2032) & (k units) Table 29. Global Dry Eye Syndrome Treatment Revenue Market Share by Type (2021-2026) Table 30. Global Dry Eye Syndrome Treatment Revenue Market Share by Type (2027-2032) Table 31. Major Manufacturers of Clinic Table 32. Major Manufacturers of Hospital Table 33. Major Manufacturers of Home Care Table 34. Global Dry Eye Syndrome Treatment Sales by Application 2021 VS 2025 VS 2032 (k units) Table 35. Global Dry Eye Syndrome Treatment Sales by Application (2021-2026) & (k units) Table 36. Global Dry Eye Syndrome Treatment Sales by Application (2027-2032) & (k units) Table 37. Global Dry Eye Syndrome Treatment Sales Market Share by Application (2021-2026) Table 38. Global Dry Eye Syndrome Treatment Sales Market Share by Application (2027-2032) Table 39. Global Dry Eye Syndrome Treatment Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 40. Global Dry Eye Syndrome Treatment Revenue by Application (2021-2026) & (k units) Table 41. Global Dry Eye Syndrome Treatment Revenue by Application (2027-2032) & (k units) Table 42. Global Dry Eye Syndrome Treatment Revenue Market Share by Application (2021-2026) Table 43. Global Dry Eye Syndrome Treatment Revenue Market Share by Application (2027-2032) Table 44. Global Dry Eye Syndrome Treatment Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 45. Global Dry Eye Syndrome Treatment Sales by Region (2021-2026) & (k units) Table 46. Global Dry Eye Syndrome Treatment Sales Market Share by Region (2021-2026) Table 47. Global Dry Eye Syndrome Treatment Sales Forecasted by Region (2027-2032) & (k units) Table 48. Global Dry Eye Syndrome Treatment Sales Forecasted Market Share by Region (2027-2032) Table 49. North America Dry Eye Syndrome Treatment Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 50. North America Dry Eye Syndrome Treatment Sales by Country (2021-2026) & (k units) Table 51. North America Dry Eye Syndrome Treatment Sales by Country (2027-2032) & (k units) Table 52. Europe Dry Eye Syndrome Treatment Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 53. Europe Dry Eye Syndrome Treatment Sales by Country (2021-2026) & (k units) Table 54. Europe Dry Eye Syndrome Treatment Sales by Country (2027-2032) & (k units) Table 55. Asia Pacific Dry Eye Syndrome Treatment Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 56. Asia Pacific Dry Eye Syndrome Treatment Sales by Country (2021-2026) & (k units) Table 57. Asia Pacific Dry Eye Syndrome Treatment Sales by Country (2027-2032) & (k units) Table 58. South America, Middle East and Africa Dry Eye Syndrome Treatment Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 59. South America, Middle East and Africa Dry Eye Syndrome Treatment Sales by Country (2021-2026) & (k units) Table 60. South America, Middle East and Africa Dry Eye Syndrome Treatment Sales by Country (2027-2032) & (k units) Table 61. Global Dry Eye Syndrome Treatment Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 62. Global Dry Eye Syndrome Treatment Revenue by Region (2021-2026) & (US$ Million) Table 63. Global Dry Eye Syndrome Treatment Revenue by Region (2027-2032) & (US$ Million) Table 64. Global Dry Eye Syndrome Treatment Revenue Market Share by Region (2021-2026) Table 65. Global Dry Eye Syndrome Treatment Revenue Market Share by Region (2027-2032) Table 66. Sun Pharmaceutical Company Information Table 67. Sun Pharmaceutical Business Overview Table 68. Sun Pharmaceutical Dry Eye Syndrome Treatment Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Sun Pharmaceutical Dry Eye Syndrome Treatment Product Portfolio Table 70. Sun Pharmaceutical Recent Development Table 71. Johnson & Johnson Company Information Table 72. Johnson & Johnson Business Overview Table 73. Johnson & Johnson Dry Eye Syndrome Treatment Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Johnson & Johnson Dry Eye Syndrome Treatment Product Portfolio Table 75. Johnson & Johnson Recent Development Table 76. Novartis Company Information Table 77. Novartis Business Overview Table 78. Novartis Dry Eye Syndrome Treatment Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Novartis Dry Eye Syndrome Treatment Product Portfolio Table 80. Novartis Recent Development Table 81. United Laboratories Company Information Table 82. United Laboratories Business Overview Table 83. United Laboratories Dry Eye Syndrome Treatment Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. United Laboratories Dry Eye Syndrome Treatment Product Portfolio Table 85. United Laboratories Recent Development Table 86. Jianfeng Group Company Information Table 87. Jianfeng Group Business Overview Table 88. Jianfeng Group Dry Eye Syndrome Treatment Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Jianfeng Group Dry Eye Syndrome Treatment Product Portfolio Table 90. Jianfeng Group Recent Development Table 91. Alcon Company Information Table 92. Alcon Business Overview Table 93. Alcon Dry Eye Syndrome Treatment Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 94. Alcon Dry Eye Syndrome Treatment Product Portfolio Table 95. Alcon Recent Development Table 96. AbbVie Company Information Table 97. AbbVie Business Overview Table 98. AbbVie Dry Eye Syndrome Treatment Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 99. AbbVie Dry Eye Syndrome Treatment Product Portfolio Table 100. AbbVie Recent Development Table 101. URSAPHARM Company Information Table 102. URSAPHARM Business Overview Table 103. URSAPHARM Dry Eye Syndrome Treatment Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 104. URSAPHARM Dry Eye Syndrome Treatment Product Portfolio Table 105. URSAPHARM Recent Development Table 106. Thea pharmaceuticals Company Information Table 107. Thea pharmaceuticals Business Overview Table 108. Thea pharmaceuticals Dry Eye Syndrome Treatment Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 109. Thea pharmaceuticals Dry Eye Syndrome Treatment Product Portfolio Table 110. Thea pharmaceuticals Recent Development Table 111. SIMILASAN Company Information Table 112. SIMILASAN Business Overview Table 113. SIMILASAN Dry Eye Syndrome Treatment Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 114. SIMILASAN Dry Eye Syndrome Treatment Product Portfolio Table 115. SIMILASAN Recent Development Table 116. Santen Pharma Company Information Table 117. Santen Pharma Business Overview Table 118. Santen Pharma Dry Eye Syndrome Treatment Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 119. Santen Pharma Dry Eye Syndrome Treatment Product Portfolio Table 120. Santen Pharma Recent Development Table 121. Rohto Company Information Table 122. Rohto Business Overview Table 123. Rohto Dry Eye Syndrome Treatment Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 124. Rohto Dry Eye Syndrome Treatment Product Portfolio Table 125. Rohto Recent Development Table 126. Prestige Consumer Healthcare Company Information Table 127. Prestige Consumer Healthcare Business Overview Table 128. Prestige Consumer Healthcare Dry Eye Syndrome Treatment Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 129. Prestige Consumer Healthcare Dry Eye Syndrome Treatment Product Portfolio Table 130. Prestige Consumer Healthcare Recent Development Table 131. OmniVision Pharma Company Information Table 132. OmniVision Pharma Business Overview Table 133. OmniVision Pharma Dry Eye Syndrome Treatment Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 134. OmniVision Pharma Dry Eye Syndrome Treatment Product Portfolio Table 135. OmniVision Pharma Recent Development Table 136. LION Company Information Table 137. LION Business Overview Table 138. LION Dry Eye Syndrome Treatment Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 139. LION Dry Eye Syndrome Treatment Product Portfolio Table 140. LION Recent Development Table 141. Kenvue (VISINE) Company Information Table 142. Kenvue (VISINE) Business Overview Table 143. Kenvue (VISINE) Dry Eye Syndrome Treatment Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 144. Kenvue (VISINE) Dry Eye Syndrome Treatment Product Portfolio Table 145. Kenvue (VISINE) Recent Development Table 146. Bausch & Lomb Company Information Table 147. Bausch & Lomb Business Overview Table 148. Bausch & Lomb Dry Eye Syndrome Treatment Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 149. Bausch & Lomb Dry Eye Syndrome Treatment Product Portfolio Table 150. Bausch & Lomb Recent Development Table 151. Akorn Company Information Table 152. Akorn Business Overview Table 153. Akorn Dry Eye Syndrome Treatment Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 154. Akorn Dry Eye Syndrome Treatment Product Portfolio Table 155. Akorn Recent Development Table 156. Key Raw Materials Table 157. Raw Materials Key Suppliers Table 158. Dry Eye Syndrome Treatment Distributors List Table 159. Dry Eye Syndrome Treatment Customers List Table 160. Research Programs/Design for This Report Table 161. Authors List of This Report Table 162. Secondary Sources Table 163. Primary Sources List of Figures Figure 1. Dry Eye Syndrome Treatment Product Image Figure 2. Global Dry Eye Syndrome Treatment Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Dry Eye Syndrome Treatment Market Size (2021-2032) & (US$ Million) Figure 4. Global Dry Eye Syndrome Treatment Sales (2021-2032) & (k units) Figure 5. Global Dry Eye Syndrome Treatment Average Price (USD/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Dry Eye Syndrome Treatment Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Liquid Wipes Image Figure 9. Liquid Drops Image Figure 10. Eye Ointment Image Figure 11. Gel Image Figure 12. Other Image Figure 13. Global Dry Eye Syndrome Treatment Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Dry Eye Syndrome Treatment Sales Market Share 2021 VS 2025 VS 2032 Figure 15. Global Dry Eye Syndrome Treatment Sales Market Share by Type (2021-2032) Figure 16. Global Dry Eye Syndrome Treatment Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 17. Global Dry Eye Syndrome Treatment Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Dry Eye Syndrome Treatment Revenue Market Share by Type (2021-2032) Figure 19. Clinic Image Figure 20. Hospital Image Figure 21. Home Care Image Figure 22. Global Dry Eye Syndrome Treatment Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 23. Global Dry Eye Syndrome Treatment Sales Market Share 2021 VS 2025 VS 2032 Figure 24. Global Dry Eye Syndrome Treatment Sales Market Share by Application (2021-2032) Figure 25. Global Dry Eye Syndrome Treatment Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 26. Global Dry Eye Syndrome Treatment Revenue Market Share 2021 VS 2025 VS 2032 Figure 27. Global Dry Eye Syndrome Treatment Revenue Market Share by Application (2021-2032) Figure 28. North America Dry Eye Syndrome Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 29. North America Dry Eye Syndrome Treatment Sales Market Share by Country (2021-2032) Figure 30. U.S. Dry Eye Syndrome Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 31. Canada Dry Eye Syndrome Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 32. Mexico Dry Eye Syndrome Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 33. Europe Dry Eye Syndrome Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 34. Europe Dry Eye Syndrome Treatment Sales Market Share by Country (2021-2032) Figure 35. Germany Dry Eye Syndrome Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 36. France Dry Eye Syndrome Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 37. U.K. Dry Eye Syndrome Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 38. Italy Dry Eye Syndrome Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 39. Netherlands Dry Eye Syndrome Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 40. Asia Pacific Dry Eye Syndrome Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 41. Asia Pacific Dry Eye Syndrome Treatment Sales Market Share by Country (2021-2032) Figure 42. China Dry Eye Syndrome Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 43. Japan Dry Eye Syndrome Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 44. South Korea Dry Eye Syndrome Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 45. Southeast Asia Dry Eye Syndrome Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 46. India Dry Eye Syndrome Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 47. Australia Dry Eye Syndrome Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 48. South America, Middle East and Africa Dry Eye Syndrome Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 49. South America, Middle East and Africa Dry Eye Syndrome Treatment Sales Market Share by Country (2021-2032) Figure 50. Brazil Dry Eye Syndrome Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 51. South Africa Dry Eye Syndrome Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 52. Saudi Arabia Dry Eye Syndrome Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 53. Turkey Dry Eye Syndrome Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 54. Argentina Dry Eye Syndrome Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 55. UAE Dry Eye Syndrome Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 56. Egypt Dry Eye Syndrome Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 57. Chile Dry Eye Syndrome Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 58. Global Dry Eye Syndrome Treatment Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Global Dry Eye Syndrome Treatment Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 60. North America Dry Eye Syndrome Treatment Revenue (2021-2032) & (US$ Million) Figure 61. North America Dry Eye Syndrome Treatment Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Europe Dry Eye Syndrome Treatment Revenue (2021-2032) & (US$ Million) Figure 63. Europe Dry Eye Syndrome Treatment Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Asia-Pacific Dry Eye Syndrome Treatment Revenue (2021-2032) & (US$ Million) Figure 65. Asia-Pacific Dry Eye Syndrome Treatment Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. South America, Middle East and Africa Dry Eye Syndrome Treatment Revenue (2021-2032) & (US$ Million) Figure 67. South America, Middle East and Africa Dry Eye Syndrome Treatment Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. Dry Eye Syndrome Treatment Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Dry Eye Syndrome Treatment Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Liquid Wipes
  • Liquid Drops
  • Eye Ointment
  • Gel
  • Other
Applications
  • Clinic
  • Hospital
  • Home Care
Companies covered
  • Sun Pharmaceutical
  • Johnson & Johnson
  • Novartis
  • United Laboratories
  • Jianfeng Group
  • Alcon
  • AbbVie
  • URSAPHARM
  • Thea pharmaceuticals
  • SIMILASAN
  • Santen Pharma
  • Rohto
  • Prestige Consumer Healthcare
  • OmniVision Pharma
  • LION
  • Kenvue (VISINE)
  • Bausch & Lomb
  • Akorn

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Dry Eye Syndrome Treatment Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Dry Eye Syndrome Treatment Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Dry Eye Syndrome Treatment Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Dry Eye Syndrome Treatment Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Dry Eye Syndrome Treatment Market Dynamics
  1. 2.1 Dry Eye Syndrome Treatment Industry Trends
  2. 2.2 Dry Eye Syndrome Treatment Industry Drivers
  3. 2.3 Dry Eye Syndrome Treatment Industry Opportunities and Challenges
  4. 2.4 Dry Eye Syndrome Treatment Industry Restraints
3 Dry Eye Syndrome Treatment Market by Manufacturers
  1. 3.1 Global Dry Eye Syndrome Treatment Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Dry Eye Syndrome Treatment Sales by Manufacturers (2021-2026)
  3. 3.3 Global Dry Eye Syndrome Treatment Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Dry Eye Syndrome Treatment Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Dry Eye Syndrome Treatment Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Dry Eye Syndrome Treatment Manufacturers, Product Type & Application
  7. 3.7 Global Dry Eye Syndrome Treatment Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Dry Eye Syndrome Treatment Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Dry Eye Syndrome Treatment Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Dry Eye Syndrome Treatment Tier 1, Tier 2, and Tier 3
4 Dry Eye Syndrome Treatment Market by Type
  1. 4.1 Dry Eye Syndrome Treatment Type Introduction
  2. 4.1.1 Liquid Wipes
  3. 4.1.2 Liquid Drops
  4. 4.1.3 Eye Ointment
  5. 4.1.4 Gel
  6. 4.1.5 Other
  7. 4.2 Global Dry Eye Syndrome Treatment Sales by Type
  8. 4.2.1 Global Dry Eye Syndrome Treatment Sales by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Dry Eye Syndrome Treatment Sales by Type (2021-2032)
  10. 4.2.3 Global Dry Eye Syndrome Treatment Sales Market Share by Type (2021-2032)
  11. 4.3 Global Dry Eye Syndrome Treatment Revenue by Type
  12. 4.3.1 Global Dry Eye Syndrome Treatment Revenue by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Dry Eye Syndrome Treatment Revenue by Type (2021-2032)
  14. 4.3.3 Global Dry Eye Syndrome Treatment Revenue Market Share by Type (2021-2032)
5 Dry Eye Syndrome Treatment Market by Application
  1. 5.1 Dry Eye Syndrome Treatment Application Introduction
  2. 5.1.1 Clinic
  3. 5.1.2 Hospital
  4. 5.1.3 Home Care
  5. 5.2 Global Dry Eye Syndrome Treatment Sales by Application
  6. 5.2.1 Global Dry Eye Syndrome Treatment Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Dry Eye Syndrome Treatment Sales by Application (2021-2032)
  8. 5.2.3 Global Dry Eye Syndrome Treatment Sales Market Share by Application (2021-2032)
  9. 5.3 Global Dry Eye Syndrome Treatment Revenue by Application
  10. 5.3.1 Global Dry Eye Syndrome Treatment Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Dry Eye Syndrome Treatment Revenue by Application (2021-2032)
  12. 5.3.3 Global Dry Eye Syndrome Treatment Revenue Market Share by Application (2021-2032)
6 Global Dry Eye Syndrome Treatment Sales by Region
  1. 6.1 Global Dry Eye Syndrome Treatment Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Dry Eye Syndrome Treatment Sales by Region (2021-2032)
  3. 6.2.1 Global Dry Eye Syndrome Treatment Sales by Region (2021-2026)
  4. 6.2.2 Global Dry Eye Syndrome Treatment Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Dry Eye Syndrome Treatment Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Dry Eye Syndrome Treatment Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Dry Eye Syndrome Treatment Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Dry Eye Syndrome Treatment Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Dry Eye Syndrome Treatment Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Dry Eye Syndrome Treatment Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Dry Eye Syndrome Treatment Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Dry Eye Syndrome Treatment Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Dry Eye Syndrome Treatment Revenue by Region
  1. 7.1 Global Dry Eye Syndrome Treatment Revenue by Region
  2. 7.1.1 Global Dry Eye Syndrome Treatment Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Dry Eye Syndrome Treatment Revenue by Region (2021-2026)
  4. 7.1.3 Global Dry Eye Syndrome Treatment Revenue by Region (2027-2032)
  5. 7.1.4 Global Dry Eye Syndrome Treatment Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Dry Eye Syndrome Treatment Revenue (2021-2032)
  8. 7.2.2 North America Dry Eye Syndrome Treatment Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Dry Eye Syndrome Treatment Revenue (2021-2032)
  11. 7.3.2 Europe Dry Eye Syndrome Treatment Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Dry Eye Syndrome Treatment Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Dry Eye Syndrome Treatment Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Dry Eye Syndrome Treatment Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Dry Eye Syndrome Treatment Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Sun Pharmaceutical
  2. 8.1.1 Sun Pharmaceutical Company Information
  3. 8.1.2 Sun Pharmaceutical Business Overview
  4. 8.1.3 Sun Pharmaceutical Dry Eye Syndrome Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Sun Pharmaceutical Dry Eye Syndrome Treatment Product Portfolio
  6. 8.1.5 Sun Pharmaceutical Recent Developments
  7. 8.2 Johnson & Johnson
  8. 8.2.1 Johnson & Johnson Company Information
  9. 8.2.2 Johnson & Johnson Business Overview
  10. 8.2.3 Johnson & Johnson Dry Eye Syndrome Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Johnson & Johnson Dry Eye Syndrome Treatment Product Portfolio
  12. 8.2.5 Johnson & Johnson Recent Developments
  13. 8.3 Novartis
  14. 8.3.1 Novartis Company Information
  15. 8.3.2 Novartis Business Overview
  16. 8.3.3 Novartis Dry Eye Syndrome Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Novartis Dry Eye Syndrome Treatment Product Portfolio
  18. 8.3.5 Novartis Recent Developments
  19. 8.4 United Laboratories
  20. 8.4.1 United Laboratories Company Information
  21. 8.4.2 United Laboratories Business Overview
  22. 8.4.3 United Laboratories Dry Eye Syndrome Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 United Laboratories Dry Eye Syndrome Treatment Product Portfolio
  24. 8.4.5 United Laboratories Recent Developments
  25. 8.5 Jianfeng Group
  26. 8.5.1 Jianfeng Group Company Information
  27. 8.5.2 Jianfeng Group Business Overview
  28. 8.5.3 Jianfeng Group Dry Eye Syndrome Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Jianfeng Group Dry Eye Syndrome Treatment Product Portfolio
  30. 8.5.5 Jianfeng Group Recent Developments
  31. 8.6 Alcon
  32. 8.6.1 Alcon Company Information
  33. 8.6.2 Alcon Business Overview
  34. 8.6.3 Alcon Dry Eye Syndrome Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Alcon Dry Eye Syndrome Treatment Product Portfolio
  36. 8.6.5 Alcon Recent Developments
  37. 8.7 AbbVie
  38. 8.7.1 AbbVie Company Information
  39. 8.7.2 AbbVie Business Overview
  40. 8.7.3 AbbVie Dry Eye Syndrome Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 AbbVie Dry Eye Syndrome Treatment Product Portfolio
  42. 8.7.5 AbbVie Recent Developments
  43. 8.8 URSAPHARM
  44. 8.8.1 URSAPHARM Company Information
  45. 8.8.2 URSAPHARM Business Overview
  46. 8.8.3 URSAPHARM Dry Eye Syndrome Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 URSAPHARM Dry Eye Syndrome Treatment Product Portfolio
  48. 8.8.5 URSAPHARM Recent Developments
  49. 8.9 Thea pharmaceuticals
  50. 8.9.1 Thea pharmaceuticals Company Information
  51. 8.9.2 Thea pharmaceuticals Business Overview
  52. 8.9.3 Thea pharmaceuticals Dry Eye Syndrome Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Thea pharmaceuticals Dry Eye Syndrome Treatment Product Portfolio
  54. 8.9.5 Thea pharmaceuticals Recent Developments
  55. 8.10 SIMILASAN
  56. 8.10.1 SIMILASAN Company Information
  57. 8.10.2 SIMILASAN Business Overview
  58. 8.10.3 SIMILASAN Dry Eye Syndrome Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 SIMILASAN Dry Eye Syndrome Treatment Product Portfolio
  60. 8.10.5 SIMILASAN Recent Developments
  61. 8.11 Santen Pharma
  62. 8.11.1 Santen Pharma Company Information
  63. 8.11.2 Santen Pharma Business Overview
  64. 8.11.3 Santen Pharma Dry Eye Syndrome Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Santen Pharma Dry Eye Syndrome Treatment Product Portfolio
  66. 8.11.5 Santen Pharma Recent Developments
  67. 8.12 Rohto
  68. 8.12.1 Rohto Company Information
  69. 8.12.2 Rohto Business Overview
  70. 8.12.3 Rohto Dry Eye Syndrome Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Rohto Dry Eye Syndrome Treatment Product Portfolio
  72. 8.12.5 Rohto Recent Developments
  73. 8.13 Prestige Consumer Healthcare
  74. 8.13.1 Prestige Consumer Healthcare Company Information
  75. 8.13.2 Prestige Consumer Healthcare Business Overview
  76. 8.13.3 Prestige Consumer Healthcare Dry Eye Syndrome Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Prestige Consumer Healthcare Dry Eye Syndrome Treatment Product Portfolio
  78. 8.13.5 Prestige Consumer Healthcare Recent Developments
  79. 8.14 OmniVision Pharma
  80. 8.14.1 OmniVision Pharma Company Information
  81. 8.14.2 OmniVision Pharma Business Overview
  82. 8.14.3 OmniVision Pharma Dry Eye Syndrome Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 OmniVision Pharma Dry Eye Syndrome Treatment Product Portfolio
  84. 8.14.5 OmniVision Pharma Recent Developments
  85. 8.15 LION
  86. 8.15.1 LION Company Information
  87. 8.15.2 LION Business Overview
  88. 8.15.3 LION Dry Eye Syndrome Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 LION Dry Eye Syndrome Treatment Product Portfolio
  90. 8.15.5 LION Recent Developments
  91. 8.16 Kenvue (VISINE)
  92. 8.16.1 Kenvue (VISINE) Company Information
  93. 8.16.2 Kenvue (VISINE) Business Overview
  94. 8.16.3 Kenvue (VISINE) Dry Eye Syndrome Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Kenvue (VISINE) Dry Eye Syndrome Treatment Product Portfolio
  96. 8.16.5 Kenvue (VISINE) Recent Developments
  97. 8.17 Bausch & Lomb
  98. 8.17.1 Bausch & Lomb Company Information
  99. 8.17.2 Bausch & Lomb Business Overview
  100. 8.17.3 Bausch & Lomb Dry Eye Syndrome Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Bausch & Lomb Dry Eye Syndrome Treatment Product Portfolio
  102. 8.17.5 Bausch & Lomb Recent Developments
  103. 8.18 Akorn
  104. 8.18.1 Akorn Company Information
  105. 8.18.2 Akorn Business Overview
  106. 8.18.3 Akorn Dry Eye Syndrome Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Akorn Dry Eye Syndrome Treatment Product Portfolio
  108. 8.18.5 Akorn Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Dry Eye Syndrome Treatment Value Chain Analysis
  2. 9.1.1 Dry Eye Syndrome Treatment Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Dry Eye Syndrome Treatment Production Mode & Process
  6. 9.2 Dry Eye Syndrome Treatment Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Dry Eye Syndrome Treatment Distributors
  9. 9.2.3 Dry Eye Syndrome Treatment Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst